Biomarin Pharmaceutical SG&A Expense (TTM) Trends

Biomarin Pharmaceutical Inc (BMRN)

81.24 +0.26 (+0.33%) USD | NASDAQ | Jul 05, 14:13

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 1999. Upgrade now.

Date	Value
March 31, 2024	940.24M
December 31, 2023	925.36M
September 30, 2023	896.06M
June 30, 2023	888.86M
March 31, 2023	870.36M
December 31, 2022	853.95M
September 30, 2022	825.85M
June 30, 2022	792.35M
March 31, 2022	779.72M
December 31, 2021	759.40M
September 30, 2021	737.30M
June 30, 2021	733.50M
March 31, 2021	724.70M
December 31, 2020	737.70M
September 30, 2020	730.08M
June 30, 2020	720.69M
March 31, 2020	705.99M
December 31, 2019	680.85M
September 30, 2019	657.19M
June 30, 2019	635.64M
March 31, 2019	628.22M
December 31, 2018	604.40M
September 30, 2018	600.46M
June 30, 2018	582.43M
March 31, 2018	572.65M

Date	Value
December 31, 2017	554.34M
September 30, 2017	537.01M
June 30, 2017	525.24M
March 31, 2017	491.31M
December 31, 2016	476.59M
September 30, 2016	447.54M
June 30, 2016	422.83M
March 31, 2016	414.76M
December 31, 2015	402.27M
September 30, 2015	388.13M
June 30, 2015	368.69M
March 31, 2015	335.27M
December 31, 2014	302.53M
September 30, 2014	274.57M
June 30, 2014	261.81M
March 31, 2014	244.38M
December 31, 2013	235.36M
September 30, 2013	218.60M
June 30, 2013	203.09M
March 31, 2013	203.98M
December 31, 2012	198.17M
September 30, 2012	191.58M
June 30, 2012	190.12M
March 31, 2012	179.60M
December 31, 2011	175.39M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (TTM) Range, Past 5 Years

657.19M

Minimum

Sep 2019

940.24M

Maximum

Mar 2024

787.38M

Average

759.40M

Median

Dec 2021

SG&A Expense (TTM) Benchmarks